Category: Uncategorized

JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives

June 10, 2021

JanOne Announces Definitive Agreement to Sell its Legacy Recycling Business for $25 Million

February 25, 2021

JanOne Announces Closing of $6.0 Million Common Stock Offering

February 2, 2021

JanOne Prices $6.0 Million Common Stock Offering

January 29, 2021

Dr. Giordano’s interview with eHealth Radio Network

December 15, 2020

JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study

September 24, 2020

JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Artery Disease

September 22, 2020

JanOne Announces Strategic Plan to Divest its Legacy Businesses

September 16, 2020

JanOne confirms stability data of JAN101 development batch and prepares for commercial GMP production to support the upcoming PAD and potential Covid-19 clinical trials

September 3, 2020

JanOne Selects Partner for Bottling and Labeling of JAN101 for Peripheral Artery Disease and Potential Covid-19 Clinical Trials

August 28, 2020